"We strive to positively impact early diagnoses, treatments, research, and survival for YOUNG adults diagnosed with LUNG CANCER"
WHY YOUNG LUNG CANCER?
Genomics are more likely to contribute to lung cancer for people who are young (under 50), have never smoked, or female.
Individuals under age 50 do not qualify for lung cancer screening. In 2018, 64% were diagnosed stage IV.
Radon is the 2nd leading cause of lung cancer and is responsible for more than 21,000 deaths in the U.S. every year.
Lung cancer diagnoses are steadily increasing among younger women.
NSCLC in individuals who have never smoked is estimated to be the 5th most common cause of cancer-related deaths worldwide.
20% of current lung cancer diagnoses occur in individuals who have never smoked.
